4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-24-000004
Chief Business Officer sold 9,786 shares at $17.23 ($168,613)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hull Hans Chief Business Officer | 2024-01-17 | Sale 10b5-1 | −9,786 | $17.23 | $168,613 | 185,069 | D |
| Open-market sales · 9,786 sh · avg $17.23 · $168,613 | |||||||
Loading xslF345X05/wk-form4_1705702751.xml…